6-30912342-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001517.5(GTF2H4):āc.973A>Gā(p.Ile325Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000062 in 1,612,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001517.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTF2H4 | NM_001517.5 | c.973A>G | p.Ile325Val | missense_variant | 11/14 | ENST00000259895.9 | NP_001508.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTF2H4 | ENST00000259895.9 | c.973A>G | p.Ile325Val | missense_variant | 11/14 | 1 | NM_001517.5 | ENSP00000259895.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000325 AC: 8AN: 245902Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 134068
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460714Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 726678
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2024 | The c.973A>G (p.I325V) alteration is located in exon 11 (coding exon 10) of the GTF2H4 gene. This alteration results from a A to G substitution at nucleotide position 973, causing the isoleucine (I) at amino acid position 325 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at